197 related articles for article (PubMed ID: 24894748)
1. A metoprolol-terbinafine combination induced bradycardia.
Bebawi E; Jouni SS; Tessier AA; Frenette AJ; Brindamour D; Doré M
Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):295-9. PubMed ID: 24894748
[TBL] [Abstract][Full Text] [Related]
2. Profound metoprolol-induced bradycardia precipitated by acetaminophen-propoxyphene.
Marraffa JM; Lang L; Ong G; Lehmann DF
Clin Pharmacol Ther; 2006 Mar; 79(3):282-6. PubMed ID: 16513452
[TBL] [Abstract][Full Text] [Related]
3. Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol.
McCollum DL; Greene JL; McGuire DK
Cardiovasc Drugs Ther; 2004 Jul; 18(4):329-30. PubMed ID: 15367832
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
Paredes AH; Lewis JH
Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).
Goryachkina K; Burbello A; Boldueva S; Babak S; Bergman U; Bertilsson L
Eur J Clin Pharmacol; 2008 Mar; 64(3):275-82. PubMed ID: 18043911
[TBL] [Abstract][Full Text] [Related]
6. [Bradycardia after beginning therapy with metoprolol and paroxetine].
König F; Häfele M; Hauger B; Löble M; Wössner S; Wolfersdorf M
Psychiatr Prax; 1996 Sep; 23(5):244-5. PubMed ID: 8992519
[TBL] [Abstract][Full Text] [Related]
7. Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib.
Qiu X; Ren B; Lian Y; Fang L; Dong Z
J Oncol Pharm Pract; 2023 Jun; 29(4):1002-1005. PubMed ID: 36380705
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent.
Thürmann PA; Haack S; Werner U; Szymanski J; Haase G; Drewelow B; Reimann IR; Hippius M; Siegmund W; May K; Hasford J
Clin Pharmacol Ther; 2006 Nov; 80(5):551-3. PubMed ID: 17112812
[No Abstract] [Full Text] [Related]
9. Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers.
Madani S; Barilla D; Cramer J; Wang Y; Paul C
J Clin Pharmacol; 2002 Nov; 42(11):1211-8. PubMed ID: 12412819
[TBL] [Abstract][Full Text] [Related]
10. The impact of CYP2D6 mediated drug-drug interaction: a systematic review on a combination of metoprolol and paroxetine/fluoxetine.
Bahar MA; Kamp J; Borgsteede SD; Hak E; Wilffert B
Br J Clin Pharmacol; 2018 Dec; 84(12):2704-2715. PubMed ID: 30248178
[TBL] [Abstract][Full Text] [Related]
11. Possible carbamazepine toxicity with terbinafine.
Baath NS; Hong J; Sattar SP
Can J Clin Pharmacol; 2006; 13(2):e228-31. PubMed ID: 16820654
[TBL] [Abstract][Full Text] [Related]
12. Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol.
Shin J; Gonzales M; Pletcher MJ
Pharmacotherapy; 2013 Dec; 33(12):1353-61. PubMed ID: 23813768
[TBL] [Abstract][Full Text] [Related]
13. Oral terbinafine-induced bullous pemphigoid.
Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M
Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide-induced sinus bradycardia.
Kaur A; Yu SS; Lee AJ; Chiao TB
Ann Pharmacother; 2003; 37(7-8):1040-3. PubMed ID: 12841816
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine and potential drug interactions.
Kaplan DL
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):882-4. PubMed ID: 11050604
[No Abstract] [Full Text] [Related]
16. [Interactions between metoprolol and antidepressants].
Molden E; Spigset O
Tidsskr Nor Laegeforen; 2011 Sep; 131(18):1777-9. PubMed ID: 21946596
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.
Wuttke H; Rau T; Heide R; Bergmann K; Böhm M; Weil J; Werner D; Eschenhagen T
Clin Pharmacol Ther; 2002 Oct; 72(4):429-37. PubMed ID: 12386645
[TBL] [Abstract][Full Text] [Related]
18. Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway.
Gedde-Dahl A; Spigset O; Molden E
Eur J Clin Pharmacol; 2022 Oct; 78(10):1623-1632. PubMed ID: 35871665
[TBL] [Abstract][Full Text] [Related]
19. Bradycardia induced by an interaction between phenelzine and beta blockers.
Reggev A; Vollhardt BR
Psychosomatics; 1989; 30(1):106-8. PubMed ID: 2913594
[No Abstract] [Full Text] [Related]
20. Pharmacokinetic model incorporating mechanism-based inactivation of CYP2D6 can explain both non-linear kinetics and drug interactions of paroxetine.
Mikami A; Ohtani H; Hori S; Sawada Y
Int J Clin Pharmacol Ther; 2013 May; 51(5):374-82. PubMed ID: 23357843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
